UK markets closed

Evaxion Biotech A/S (EVAX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.9500+0.0600 (+1.54%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
5,583
13,184
32,166
5,834
Total cash
5,583
13,184
32,166
5,834
Total current assets
8,350
16,985
34,705
10,950
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,509
5,396
5,490
520
Accumulated depreciation
-1,166
-721
-316
-299
Net property, plant and equipment
4,343
4,675
5,174
221
Other long-term assets
-
-
-
2
Total non-current assets
4,539
5,040
5,458
1,015
Total assets
12,889
22,025
40,163
11,965
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
159
136
126
-
Accounts payable
2,689
2,085
2,848
3,673
Other current liabilities
3,016
885
46
180
Total current liabilities
7,084
3,762
4,323
4,927
Non-current liabilities
Long-term debt
8,489
7,864
1,044
-
Other long-term liabilities
10
-
-
-
Total non-current liabilities
10,544
9,960
3,403
0
Total liabilities
17,628
13,722
7,726
4,927
Stockholders' equity
Common stock
5,899
3,886
3,755
2,648
Retained earnings
-107,970
-85,845
-50,432
-27,279
Accumulated other comprehensive income
-3,773
-3,651
-1,316
31,669
Total stockholders' equity
-4,739
8,303
32,437
7,038
Total liabilities and stockholders' equity
12,889
22,025
40,163
11,965